Long-Term Complete Response to Pembrolizumab in Tumor Mutation Burden-High Small Cell Lung Cancer: A Case Report
We report a rare case of a long-term response to pembrolizumab in ED-SCLC with TMB-high, highlighting the potential for targeted immunotherapy in such cases.
Authors
- Takahisa Kawamura (ORCID: https://orcid.org/0000-0001-6611-659X)
- Kazumi Nishino (ORCID: https://orcid.org/0000-0003-2000-7472)
- Shun Futamura
- Motohiro Tamiya (ORCID: https://orcid.org/0000-0001-6529-3092)
- Akito Miyazaki (ORCID: https://orcid.org/0009-0004-7188-674X)
- Tsunehiro Tanaka (ORCID: https://orcid.org/0000-0001-6351-2992)
- Kei Kunimasa (ORCID: https://orcid.org/0000-0002-5241-3486)
- Kiyohide Komuta
- Takako Inoue
Institutions
- Osaka International Cancer Institute (JP)
Publication Details
- Journal
- Case Reports in Oncology
- Published
- 2025-03-06
- DOI
- https://doi.org/10.1159/000544103
- Primary Topic
- Lung Cancer Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00